This suggests that innate immunity is excessively activated while adaptive immunity is suppressed during the development of early-onset preeclampsia, and NFAT-1, STAT1, and AP-1 may serve as core transcription factors maintaining the equilibrium between innate and adaptive immune responses in the pathogenesis of early-onset preeclampsia (63). This evidence concerns the gene NFATC2 and preeclampsia.